Bellerophon Therapeutics Inc (BLPH) - Financial and Strategic SWOT Analysis Review

  • ID: 4285100
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage bio therapeutics company which develops products with the combination of drugs and devices for the treatment of cardiopulmonary diseases. The company is currently developing three product candidates under INOpulse platform, a proprietary pulsatile nitric oxide device system, for the treatment of pulmonary arterial hypertension (PAH), pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). The company offers drugs candidates for the treatment of PAH and PH-COPD which are in Phase III and Phase II clinical trials. Bellerophon Therapeutics is headquartered in Warren, New Jersey, the US.

Bellerophon Therapeutics Inc Key Recent Developments

Nov 30, 2017: Bellerophon Appoints Ted Wang, Ph.D., of Puissance Capital Management, to its Board of Directors
Nov 07, 2017: Bellerophon Provides Business Update and Reports Third Quarter 2017 Financial Results
Aug 07, 2017: Bellerophon Reports Second Quarter 2017 Financial Results and Provides Business Update
May 15, 2017: Bellerophon Reports First Quarter 2017 Financial Results and Provides Business Update
Mar 13, 2017: Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update

This comprehensive SWOT profile of Bellerophon Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Bellerophon Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Bellerophon Therapeutics Inc - Key Information
  • Bellerophon Therapeutics Inc - Overview
  • Bellerophon Therapeutics Inc - Key Employees
  • Bellerophon Therapeutics Inc - Key Employee Biographies
  • Bellerophon Therapeutics Inc - Key Operational Heads
  • Bellerophon Therapeutics Inc - Major Products and Services
  • Bellerophon Therapeutics Inc - History
  • Bellerophon Therapeutics Inc - Company Statement
  • Bellerophon Therapeutics Inc - Locations And Subsidiaries
  • Bellerophon Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Bellerophon Therapeutics Inc - Business Description
  • Bellerophon Therapeutics Inc - Corporate Strategy
  • Bellerophon Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Bellerophon Therapeutics Inc - Strengths
  • Bellerophon Therapeutics Inc - Weaknesses
  • Bellerophon Therapeutics Inc - Opportunities
  • Bellerophon Therapeutics Inc - Threats
  • Bellerophon Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Bellerophon Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Bellerophon Therapeutics Inc, Key Information
  • Bellerophon Therapeutics Inc, Key Ratios
  • Bellerophon Therapeutics Inc, Share Data
  • Bellerophon Therapeutics Inc, Major Products and Services
  • Bellerophon Therapeutics Inc, History
  • Bellerophon Therapeutics Inc, Key Employees
  • Bellerophon Therapeutics Inc, Key Employee Biographies
  • Bellerophon Therapeutics Inc, Key Operational Heads
  • Bellerophon Therapeutics Inc, Other Locations
  • Bellerophon Therapeutics Inc, Subsidiaries
  • Bellerophon Therapeutics Inc, Key Manufacturing facilities
  • Bellerophon Therapeutics Inc, Key Competitors
  • Bellerophon Therapeutics Inc, SWOT Analysis
  • Bellerophon Therapeutics Inc, Ratios based on current share price
  • Bellerophon Therapeutics Inc, Annual Ratios
  • Bellerophon Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Bellerophon Therapeutics Inc, Performance Chart
  • Bellerophon Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll